PRRT2 and breast cancer: Aim of this study was to assess the efficiency of AEB071-based PKC targeting in ER-positive (T-47D), ER/HER2 double positive (BT474), and triple negative (HCC1806) BC cell lines subjected to 2D, 3D-mono, and 3D-coculture conditions.